Maia Biotechnology Inc
maiabiotech.comWhat Do They Do?
Develops a cancer drug in clinical trials for people with non-small cell lung cancer and is studying it for other cancers.
10-K for FY2025, filed Mar 23, 2026
How Do They Make Money?
No revenue reported yet.
10-K for FY2024, filed Mar 21, 2025
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 10, 2026
−$7.9MView ↗
- ▲ +49% (Loss)
- vs −$5.3M in Q2 FY2025
Who Do They Compete With?
Competes with Merck, Regeneron, Eli Lilly, and Roche
10-K for FY2025, filed Mar 23, 2026Any therapeutic candidates that we successfully develop and commercialize will compete with currently approved therapies and new therapies…View ↗
Loading...
